SCHEMBL8533679

SCHEMBL8533679

CC(C)(C)OC(=O)n1ccc2cc(N3CCCC3=O)ccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 2/20 0.43
ABL1 P00519 2/20 0.43
EGFR P00533 2/20 0.43
HCK P08631 2/20 0.43
SRC P12931 2/20 0.43
KDR P35968 2/20 0.43
PIK3CA P42336 2/20 0.43
PIK3CB P42338 2/20 0.43
MTOR P42345 2/20 0.43
PIK3CG P48736 2/20 0.43
EPHB4 P54760 2/20 0.43
PRKDC P78527 2/20 0.43
PI4KB Q9UBF8 2/20 0.43
ALDH1A1 P00352 6/20 0.42
HPGD P15428 4/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13665296 0.87 PIK3CD (0.41) PIK3CDABL1EGFRHCKSRC
SCHEMBL2002026 0.87 BRD9 (0.42) PIK3CDABL1EGFRHCKSRC
SCHEMBL8533712 0.82 PIK3CD (0.44) PIK3CDABL1EGFRHCKSRC
SCHEMBL15253302 0.82 ALDH1A1 (0.52) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL3834511 0.81 HTR6 (0.44) PIK3CDABL1EGFRHCKSRC
SCHEMBL948951 0.78 HTR6 (0.47) PIK3CDABL1EGFRHCKSRC
SCHEMBL312329 0.75 PIK3CD (0.51) PIK3CDABL1EGFRHCKSRC
SCHEMBL3872052 0.74 ESR2 (0.56) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL6394140 0.74 PIK3CD (0.45) PIK3CDABL1EGFRHCKSRC
SCHEMBL3783884 0.74 CYP11B1 (0.41) PIK3CDABL1EGFRHCKSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9000175-B2 Bicyclic GPR119 modulators LUPIN LIMITED (IN) 2015-04-07 US disclosed
EP-2643311-A1 BICYCLIC GPR119 MODULATORS Lupin Limited (IN) 2013-10-02 EP disclosed
US-20130245000-A1 BICYCLIC GPR119 MODULATORS LUPIN LIMITED (IN) 2013-09-19 US disclosed
WO-2012069917-A1 BICYCLIC GPR119 MODULATORS LUPIN LIMITED (IN) 2012-05-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130245000-A1 BICYCLIC GPR119 MODULATORS GPR119, GPR180, GPBAR1 PIK3CD 2657/4885ABL1 2736/4885EGFR 2194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.